Table 6

Clinical outcomes during 1-year follow-up

None/mild TR, n=36Moderate/severe TR, n=44P value
In-hospitalisation for heart failure8 (22)21 (48)0.021
Cardiac death6 (17)16 (36)0.077
Second MitraClip1 (2.8)2 (4.5)1
Surgical mitral valve revision1 (2.8)2 (4.5)1
LVAD implantation0 (0)2 (4.5)0.50
NYHA grade of survivors2.5±0.88 (n=28)2.37±0.69 (n=27)0.55
  • LVAD, left ventricular assist device; NYHA, New York Heart Association; TR, tricuspid regurgitation.